Johnson & Johnson to acquire Firefly Bio for $1 billion
Johnson & Johnson (NYSE:JNJ) announced today that it has entered into a definitive agreement to acquire Firefly Bio for $1 billion in cash.
Todas as matérias desta categoria, das mais recentes às mais antigas.
Johnson & Johnson (NYSE:JNJ) announced today that it has entered into a definitive agreement to acquire Firefly Bio for $1 billion in cash.
MetaVia (NASDAQ:MTVA) has reported new data from its cardiometabolic pipeline at the American Diabetes Association’s (ADA) 2026 Scientific Sessions in New Orleans.
Neurocrine Biosciences (NASDAQ:NBIX) has announced new clinician-reported data highlighting the effectiveness of INGREZZA (valbenazine) in treating tardive dyskinesia (TD) among individuals with intellectual and developmental disabilities (IDD).
Galmed Pharmaceuticals (NASDAQ:GLMD) has entered into a definitive agreement to acquire Colospan, a commercial-stage medical device company specializing in gastrointestinal surgery solutions.
Ingredion (NYSE:INGR) announced on Monday a definitive agreement to acquire the UK-based ingredients specialist Tate & Lyle in an all-cash transaction.
Alliance Resource Partners (NASDAQ:ARLP) announced on June 8, 2026, that it has entered into definitive agreements to acquire general partner and limited partner interests in AllDale Minerals III, LP and AllDale Minerals IV, LP (collectively, “AllDale III & IV”) for approximately $206.2 million.
FOX (NASDAQ:FOX) has finalized a multi-year agreement with the National Football League to serve as a broadcast partner for NFL content in Mexico.
Cameron Dawson, CIO at NewEdge Wealth, says semiconductor stocks are "nowhere near oversold" after last week's selloff.
Seaport Therapeutics (NASDAQ:SPTX) announced its financial results for the first quarter ended March 31, 2026, marking a pivotal period of transition for the Boston-based biotech as it enters the public markets.
Incyte (NASDAQ:INCY) announced today that it has entered into a definitive agreement to acquire Vega Therapeutics, a wholly owned subsidiary of Star Therapeutics, for an upfront payment of $1.25 billion.
US President Donald Trump said Israel and Iran are looking to agree to an immediate ceasefire following a series of strikes, while Iran's central military command says the military operation against Israel has ended, according to semi-official Fars news agency. Tyler Kendall reports on Bloomberg Television.
RedHill Biopharma (NASDAQ:RDHL) announced on June 8, 2026, that it has officially commenced recognition and enforcement proceedings in South Korea to collect on a final judgment awarded by the New York Supreme Court against Kukbo.
Tem um segundo para um cookie? 🍪Os cookies essenciais mantêm a Grafa funcionando bem. Alguns opcionais nos ajudam a ver o que está funcionando para melhorarmos. Você tem o controle — pode mudar de ideia quando quiser. Política de cookies · Política de privacidade